{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:16:06Z","timestamp":1764936966500,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00277-018-3293-x","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T22:00:54Z","timestamp":1522188054000},"page":"1251-1258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma"],"prefix":"10.1007","volume":"97","author":[{"given":"Vanessa","family":"Desantis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonia","family":"Frassanito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Tamma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Saltarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelia","family":"Lamanuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Giovanni","family":"Solimando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Annese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Nico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4768-8431","authenticated-orcid":false,"given":"Domenico","family":"Ribatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"3293_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","volume":"87","author":"A Vacca","year":"1994","unstructured":"Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87:503\u2013508","journal-title":"Br J Haematol"},{"key":"3293_CR2","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1038\/sj.onc.1209456","volume":"25","author":"D Ribatti","year":"2006","unstructured":"Ribatti D, Nico B, Vacca A (2006) Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25:4257\u20134266","journal-title":"Oncogene"},{"key":"3293_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/leu.2013.254","volume":"28","author":"MA Frassanito","year":"2013","unstructured":"Frassanito MA, Rao L, Moschetta M, Ria R, Di Marzo L, De Luisi A, Racanelli V, Catacchio I, Berardi S, Basile A et al (2013) Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies. Leukemia 28:904\u2013916","journal-title":"Leukemia"},{"key":"3293_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/scd.2007.0132","volume":"17","author":"B Nico","year":"2008","unstructured":"Nico B, Mangieri D, Crivellato E, Vacca A, Ribatti D (2008) Mast cells contribute to vasculogenic mimicry in multiple myeloma. Stem Cells Dev 17:19\u201322","journal-title":"Stem Cells Dev"},{"key":"3293_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.bjc.6690070","volume":"79","author":"D Ribatti","year":"1999","unstructured":"Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M, Marzullo A, Herken R, Roncali L (1999) Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 79:451\u2013455","journal-title":"Br J Cancer"},{"key":"3293_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/sj.onc.1210691","volume":"27","author":"C Scavelli","year":"2007","unstructured":"Scavelli C, Nico B, Cirulli T, Ria R, Di Pietro G, Mangieri D, Bacigalupo A, Mangialardi G, Coluccia AML, Caravita T et al (2007) Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene 27:663\u2013674","journal-title":"Oncogene"},{"key":"3293_CR7","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1182\/blood-2003-04-1338","volume":"102","author":"A Vacca","year":"2003","unstructured":"Vacca A, Ria R , Semeraro F, Merchionne F, Coluccia M, Boccarelli A, Scavelli C, Nico B, Gernone A, Battelli F et al. (2003) Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 102:3340\u20133348","journal-title":"Blood"},{"key":"3293_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.59.2.3","volume":"59","author":"D Ribatti","year":"2007","unstructured":"Ribatti D, Conconi MT, Nussdorfer GG (2007) Nonclassic endogenous novel regulators of angiogenesis. Pharmacol Rev 59:185\u2013205","journal-title":"Pharmacol Rev"},{"key":"3293_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/B978-0-12-394310-1.00005-9","volume":"299","author":"D Ribatti","year":"2012","unstructured":"Ribatti D (2012) Angiogenic effects of erythropoietin. Int Rev Cell Mol Biol 299:199\u2013234","journal-title":"Int Rev Cell Mol Biol"},{"key":"3293_CR10","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","volume":"93","author":"D Ribatti","year":"1999","unstructured":"Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93:2627\u20132636","journal-title":"Blood"},{"key":"3293_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10456-013-9369-2","volume":"16","author":"A Luisi De","year":"2013","unstructured":"De Luisi A, Binetti L, Ria R, Ruggieri S, Berardi S, Catacchio I, Racanelli V, Pavone V, Rossini B, Vacca A et al (2013) Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma. Angiogenesis 16:963\u2013973","journal-title":"Angiogenesis"},{"key":"3293_CR12","doi-asserted-by":"publisher","first-page":"14510","DOI":"10.18632\/oncotarget.7587","volume":"7","author":"A Lamanuzzi","year":"2016","unstructured":"Lamanuzzi A, Saltarella I, Ferrucci A, Ria R, Ruggieri S, Racanelli V, Rao L, Annese T, Nico B, Vacca A, Ribatti D (2016) Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients. Oncotarget 7:14510\u201314521","journal-title":"Oncotarget"},{"key":"3293_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"3293_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nprot.2006.13","volume":"1","author":"D Ribatti","year":"2006","unstructured":"Ribatti D, Nico B, Vacca A, Presta M (2006) The gelatin sponge\u2013chorioallantoic membrane assay. Nat Protoc 1:85\u201391","journal-title":"Nat Protoc"},{"key":"3293_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/ham.2015.0015","volume":"16","author":"J Su","year":"2015","unstructured":"Su J, Li Z, Cui S, Ji L, Geng H, Chai K, Ma X, Bai Z, Yang Y, Wuren T, Ge RL, Rondina MT (2015) The local HIF-2\u03b1\/EPO pathway in the bone marrow is associated with excessive erythrocytosis and the increase in bone marrow microvessel density in chronic mountain sickness. High Altitude Med Biol 16:318\u2013330","journal-title":"High Altitude Med Biol"},{"unstructured":"Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR (2000) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002\u20135011","key":"3293_CR16"},{"key":"3293_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121:335\u2013348","journal-title":"Cell"},{"key":"3293_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez N, Truitt M, Olson P, Hanahan D (2010) Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-\u03baB-dependent manner. Cancer Cell 17:135\u2013147","journal-title":"Cancer Cell"},{"key":"3293_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000440995","volume":"133","author":"L-P Wang","year":"2015","unstructured":"Wang L-P, Yang X-H, Wang X-J, Li S-M, Sun N, Zhang T (2015) Erythropoietin decreases the occurrence of myocardial fibrosis by inhibiting the NADPH-ERK-N-kB pathway. Cardiology 133:97\u2013108","journal-title":"Cardiology"},{"key":"3293_CR20","first-page":"608","volume":"23","author":"HL Jiang","year":"2011","unstructured":"Jiang HL, Zhu YC, Chen XH, Lin PY, Wang HJ (2011) The myocardium protective effects of erythropoietin (EPO) in a rat model of asphyxia-induced cardiac arrest\/cardiopulmonary resuscitation (CPR). Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23:608\u2013612","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"3293_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cardiores.2006.06.003","volume":"71","author":"Y Li","year":"2006","unstructured":"Li Y, Takemura G, Okada H, Miyata S, Maruyama R, Li L, Higuchi M, Minatoguchi S, Fujiwara T, Fujiwara H (2006) Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 71:684\u2013694","journal-title":"Cardiovasc Res"},{"key":"3293_CR22","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.3892\/mmr.2015.3157","volume":"11","author":"XC Geng","year":"2015","unstructured":"Geng XC, Hu ZP, Lian GY (2015) Erythropoietin ameliorates renal interstitial fibrosis via the inhibition of fibrocyte accumulation. Mol Med Rep 11:3860\u20133865","journal-title":"Mol Med Rep"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3293-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T08:05:21Z","timestamp":1604045121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3293-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3293"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3293-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2018,3,28]]},"assertion":[{"value":"1 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest and that they do not have a financial relationship with the organization that sponsored the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}